<p>Adverse events: local and systemic adverse events 21 days after first dose and 42 days after the first dose in the three groups: HIV-infected who received single doses, HIV-infected who received double doses, and HIV-negative.</p
Introduction: The new direct acting antivirals (DAA) have demonstrated low rates of adverse effects ...
Introduction: The new direct acting antivirals (DAA) have demonstrated low rates of adverse effects ...
INTRODUCTION: Patients initiated on highly active antiretroviral therapy (HAART) generally remain on...
The occurrence of adverse events after receiving the first and second dose in the participants with ...
The occurrence of adverse events after receiving the first and second dose in the participants with ...
<p>Frequency of Serious Adverse Drug Reactions by HIV status and months of treatment.</p
Adverse events following first and second immunization of COVID-19 among the participants.</p
<p>The x-axis shows the number of participants experiencing adverse events, with the highest severit...
Adverse reactions to drugs are frequently encountered in patients with HIV and AIDS, particularly th...
Context: The advancement and development of new drugs and treatment strategies increase the risk of ...
<p>The x-axis shows the number of participants experiencing adverse events, with the highest severit...
HIV/AIDS remains the greatest public health concern in the world. With current scenario, HIV/AIDS is...
<p>Solicited adverse events following booster vaccination or in case of clade 2 primary vaccination ...
INTRODUCTION: Patients initiated on highly active antiretroviral therapy (HAART) generally remain on...
Adverse events recorded within day 0 to day 3 after MDA using dihydroartemisinin-piperaquine.</p
Introduction: The new direct acting antivirals (DAA) have demonstrated low rates of adverse effects ...
Introduction: The new direct acting antivirals (DAA) have demonstrated low rates of adverse effects ...
INTRODUCTION: Patients initiated on highly active antiretroviral therapy (HAART) generally remain on...
The occurrence of adverse events after receiving the first and second dose in the participants with ...
The occurrence of adverse events after receiving the first and second dose in the participants with ...
<p>Frequency of Serious Adverse Drug Reactions by HIV status and months of treatment.</p
Adverse events following first and second immunization of COVID-19 among the participants.</p
<p>The x-axis shows the number of participants experiencing adverse events, with the highest severit...
Adverse reactions to drugs are frequently encountered in patients with HIV and AIDS, particularly th...
Context: The advancement and development of new drugs and treatment strategies increase the risk of ...
<p>The x-axis shows the number of participants experiencing adverse events, with the highest severit...
HIV/AIDS remains the greatest public health concern in the world. With current scenario, HIV/AIDS is...
<p>Solicited adverse events following booster vaccination or in case of clade 2 primary vaccination ...
INTRODUCTION: Patients initiated on highly active antiretroviral therapy (HAART) generally remain on...
Adverse events recorded within day 0 to day 3 after MDA using dihydroartemisinin-piperaquine.</p
Introduction: The new direct acting antivirals (DAA) have demonstrated low rates of adverse effects ...
Introduction: The new direct acting antivirals (DAA) have demonstrated low rates of adverse effects ...
INTRODUCTION: Patients initiated on highly active antiretroviral therapy (HAART) generally remain on...